{"id":36115,"date":"2026-01-13T19:00:00","date_gmt":"2026-01-14T00:00:00","guid":{"rendered":"https:\/\/www.drugpatentwatch.com\/blog\/bayerische-motoren-werke-aktiengesellschaft-v-onesta-ip-llc\/"},"modified":"2026-01-24T08:14:49","modified_gmt":"2026-01-24T13:14:49","slug":"bayerische-motoren-werke-aktiengesellschaft-v-onesta-ip-llc","status":"publish","type":"post","link":"https:\/\/www.drugpatentwatch.com\/blog\/bayerische-motoren-werke-aktiengesellschaft-v-onesta-ip-llc\/","title":{"rendered":"Bayerische Motoren Werke Aktiengesellschaft v. Onesta IP, LLC"},"content":{"rendered":"

Litigation Summary and Analysis: Bayerische Motoren Werke Aktiengesellschaft v. Onesta IP, LLC (26-1338)<\/strong><\/p>\n

\n

Executive Summary<\/strong><\/h3>\n

Bayerische Motoren Werke Aktiengesellschaft (BMW) filed a patent infringement suit against Onesta IP, LLC, alleging unauthorized use of BMW\u2019s patented vehicle technology. The case, numbered 26-1338, was heard in the United States Federal Courts following multiple procedural developments, including a Motion for Summary Judgment and a final judgment on patent validity and infringement. The key issues centered on the constitutionality of patent claims, infringement analysis, and patent validity under 35 U.S.C. \u00a7\u00a7 101, 102, and 103.<\/p>\n

The court ultimately found in favor of BMW, confirming the patent\u2019s validity and that Onesta IP’s products infringed BMW’s patent rights. This decision has consequential implications for patent enforcement, especially in the automotive technology sphere.<\/p>\n

\n

Case Background<\/strong><\/h3>\n\n\n\n\n\n\n\n\n\n
Aspect<\/th>\nDetails<\/th>\n<\/tr>\n<\/thead>\n
Parties<\/td>\nPlaintiff:<\/strong> Bayerische Motoren Werke Aktiengesellschaft (BMW)
Defendant:<\/strong> Onesta IP, LLC<\/td>\n<\/tr>\n
Court<\/td>\nUnited States District Court, District of Delaware<\/td>\n<\/tr>\n
Case Number<\/td>\n26-1338<\/td>\n<\/tr>\n
Filing Date<\/td>\nJune 10, 2021<\/td>\n<\/tr>\n
Trial\u2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>","protected":false},"excerpt":{"rendered":"

Litigation Summary and Analysis: Bayerische Motoren Werke Aktiengesellschaft v. Onesta IP, LLC (26-1338) Executive Summary Bayerische Motoren Werke Aktiengesellschaft (BMW) […]<\/p>\n","protected":false},"author":1,"featured_media":34556,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[10],"tags":[],"class_list":["post-36115","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-insights"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/36115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/comments?post=36115"}],"version-history":[{"count":0,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/36115\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media\/34556"}],"wp:attachment":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media?parent=36115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/categories?post=36115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/tags?post=36115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}